Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age

The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome

(2020) Yabo Yang et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡

(2018) Helena J Teede et al.   HUMAN REPRODUCTION

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

(2018) Héctor F. Escobar-Morreale   Nature Reviews Endocrinology

Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome

(2016) D.J. Handelsman et al.   HUMAN REPRODUCTION

The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome

(2013) Dimitrios Panidis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria

(2012) B. O. Yildiz et al.   HUMAN REPRODUCTION

Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40

(2011) S.-J. Liang et al.   HUMAN REPRODUCTION

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society

(2011) H.F. Escobar-Morreale et al.   HUMAN REPRODUCTION UPDATE

Modified Ferriman–Gallwey hirsutism score and androgen levels in Turkish women

(2010) Ayhan Coskun et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Cycle and hormone changes during perimenopause

(2009) Henry G. Burger et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Consensus on infertility treatment related to polycystic ovary syndrome

(2008)   HUMAN REPRODUCTION